Previous Article | Next Article 
Journal of Virology, April 2000, p. 3410-3412, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Fatty Acid-Depleted Albumin Induces the Formation
of Echovirus A Particles
Trevor
Ward,1,2
Robert M.
Powell,2
Yasmin
Chaudhry,1
Janet
Meredith,2
Jeffrey W.
Almond,2,
Werner
Kraus,3
Birgit
Nelsen-Salz,3
Hans J.
Eggers,3 and
David J.
Evans1,*
Division of Virology, Institute of Biomedical
and Life Sciences, University of Glasgow, Glasgow G11 5JR, United
Kingdom1; School of Animal and Microbial
Sciences, University of Reading, Whiteknights, Reading RG6 6AJ, United
Kingdom2; and Institut für
Virologie der Universität zu Köln, 50935 Cologne,
Germany3
Received 3 September 1999/Accepted 21 December 1999
 |
ABSTRACT |
Picornavirus infection requires virus uncoating, associated with
the production of 135S "A" particles and 80S empty particles from
160S mature virions, to release the RNA genome into the cell cytoplasm.
Normal albumin inhibits this process. We now show that when depleted of
fatty acids, albumin induces the formation of echovirus A particles.
 |
TEXT |
Echoviruses (EVs), members of the
Enterovirus genus of the family Picornaviridae,
are small positive-strand RNA viruses with icosahedral symmetry which
produce a broad spectrum of diseases in humans (8).
Productive cell infection requires the uncoating of the virus particle
and release of the RNA genome into the cell cytoplasm. The conversion
of the 160S mature virions into 135S A and 80S empty particles
(reviewed in reference 14) is considered indicative
of this process. Poliovirus A particle formation can be induced by
soluble poliovirus receptor (6, 20), whereas soluble
decay-accelerating factor, a receptor for a number of enteroviruses
including EV12 (17), does not induce EV A particles (12). Moreover, conversion of poliovirus to A particles is
rapid compared with the conversion of EV (12). Both
uncoating and the thermal stability of virions are thought to be
regulated by the presence of "pocket factors" in the hydrophobic
pocket at the base of the canyon floor. Known pocket factors are fatty
acid (FA) or FA based; poliovirus uses sphingosine (14),
coxsackievirus B3 and EV1 both use palmitate (3, 11), and
bovine enterovirus uses myristate (15). Enterovirus
uncoating can be inhibited by pocket factor mimetics like WIN compounds
(10, 14) and by the pocket factor itself (5). The
uncoating of EV, but not poliovirus, can also be blocked by normal
albumin (18); since this protein contains FAs
(7), we considered the possibility that FAs were responsible
for this block. However, FA-depleted albumin also blocks EV infection
(18). We have now investigated the block on EV infection
caused by FA-depleted albumin by using wild-type (WT) EV12 and three
thermolabile rhodanine-resistant EV12 mutants (1, 2, 8).
Normal bovine serum albumin (A-7638; Sigma) and FA-depleted albumin
(A-0281; Sigma) were solubilized in serum-free Dulbecco modified Eagle
medium (DMEM) (final pH 7.4). EV12 and the rhodanine-resistant mutants
numbered 9, 17, and 20 were incubated for 1 h at 37°C with
normal or FA-depleted albumin (2%, wt/vol), or rhodanine (200 µg/ml). Virus was then diluted in serum-free DMEM and adsorbed to
24-well plates of rhabdomyosarcoma (RD) cells at 95% confluency for 30 min. Cells were incubated in serum-free DMEM, and at 7 h
postinfection, cells were assayed for infected cells by using an
immunofocal assay (18). Preincubation of WT EV12 or mutants 17 or 20 with normal albumin and rhodanine did not affect infectivity, whereas infection by mutant 9 was enhanced by 180% (Fig.
1). In contrast, infectivity of all the
viruses was reduced after preincubation with FA-depleted albumin; WT
EV12 was decreased by 50%, and infectivity of the more thermolabile
rhodanine mutants (8) was reduced by 70% (mutant 17) to
greater than 99% (mutants 9 and 20). The rhodanine mutants map to an
internal region next to the threefold axis of symmetry that is known to
modulate virion stability (8). Mutants 9 and 17, respectively, have substitutions of V157A and V101A in VP1, whereas mutant 20 has a mutation of
F53Y in VP4. Preincubation with FA-depleted albumin was
also found to reduce the infectivity of EV7, but not of poliovirus
(data not shown). These results indicate that the reduction in EV
infectivity induced by preincubation with FA-depleted albumin is
irreversible and that the more thermolabile rhodanine-resistant mutants
are more susceptible to FA-depleted albumin mediated inactivation.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 1.
EV12 infection is irreversibly inhibited by FA-depleted
albumin. Virus (106 50% tissue culture infective doses/ml)
was preincubated with serum-free DMEM containing normal or FA-depleted
albumin (2%, wt/vol) or rhodanine (200 µg/ml) for 1 h at
37°C. After dilution in serum-free DMEM, virus infectivity was
determined by using a blue-cell immunofocal assay with the
anti-enterovirus monoclonal antibody 5-D8/1 (18, 19).
|
|
35S-radiolabelled WT EV12 (approximately 40,000 cpm) in
500-µl volumes of serum-free DMEM with or without normal or
FA-depleted albumin (2%) was incubated for 0 to 6 h at 37°C.
Virus binding to RD cells was then determined on ice (17,
19). Pretreatment of virus with FA-depleted albumin significantly
reduced virus binding, whereas pretreatment with serum-free DMEM or
normal albumin had no effect (Fig. 2). A
similar reduction in virus binding was found for EV7 pretreated with
FA-depleted albumin, but not with normal albumin (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Pretreatment of WT EV12 with FA-depleted albumin
inhibits virus binding. RD cells were incubated on ice for 1 h
with 35S-radiolabelled WT EV12 (approximately 40,000 cpm)
that had been preincubated in serum-free DMEM with or without normal or
FA-depleted albumin (2%, wt/vol) from 0 to 6 h at 37°C. After
adsorption for 30 min on ice, cells were washed to remove nonadsorbed
counts, and quantity of bound virus was determined by scintillation
counting.
|
|
The buoyant density of the FA-depleted albumin-treated virus was
investigated by sucrose gradient analysis to determine whether the
formation of 135S A particles had been induced (Fig.
3). 35S-radiolabelled WT EV12
(approximately 40,000 cpm) in 1-ml volumes of serum-free DMEM
containing either normal or FA-depleted albumin (2%) was incubated for
2 h at 37°C. Virus was then sedimented through parallel 15 to
45% sucrose gradients for 4.5 h at 25,000 rpm in a Beckman SW28
rotor, and fractions were quantified by scintillation counting. When
treated with normal albumin, the majority of virions remained at 160S.
In contrast, when treated with FA-depleted albumin, most of the virus
was converted to 135S A particles. Both normal and FA-depleted albumin
also generated a smaller peak of 80S empty particles; since the input
material was gradient-purified 160S particles, one interpretation is
that the 80S particles may be derived directly from 160S particles rather than from a 135S A particle intermediate.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
FA-depleted albumin induces A particle formation of WT
EV12. 35S-radiolabelled WT EV12 (40,000 cpm) was incubated
at 37°C for 2 h in the presence of either normal or FA-depleted
albumin. Virus was then sedimented through parallel 15 to 45% sucrose
gradients for 4.5 h at 25,000 rpm in a Beckman SW28 rotor, and the
radioactivity in fractions was quantified by scintillation counting.
|
|
The results of this investigation suggest that normal and FA-depleted
albumin block EV infection by different mechanisms. We suggest
FA-depleted albumin probably induces A particle formation by stripping
stabilizing pocket factors from mature virions; the greater loss of
infectivity of the thermolabile mutants compared with WT EV12 supports
this conclusion. Conversely, the increase in the thermal stability of
mutant 9 induced by normal albumin (Fig. 1) and the observation that
this protein blocks EV uncoating (18) suggest that albumin
or the FA associated with it has EV-stabilizing properties.
The induction of EV A particle formation by FA-depleted albumin
demonstrates that this process can be promoted by a protein other than
the receptor. Furthermore, unlike poliovirus, EV uncoating can be
blocked by normal albumin (18), antibodies to
2-microglobulin (reference 19 and unpublished
data), and CD59 (4). Taken together, these results suggest
that poliovirus and EVs may have different strategies for coupling
thermal stability with the associated process of uncoating; these
differences may be pivotal in influencing the pathogenic nature of
these viruses. It has previously been suggested that a factor(s) other
than humoral antibodies may modulate EV-associated meningitis, which is
often self-limiting (9, 16), and we have already proposed
that the influx of albumin into the cerebrospinal fluid during
EV-induced meningitis may prevent further virus replication and host
tissue injury (18). Based on the results presented here, we
speculate that factors such as age, diet, stress, and diabetes
all of
which affect the plasma levels of FA (13)
may also
influence EV pathology by modulating virus dissemination and uncoating.
 |
ACKNOWLEDGMENTS |
We thank Barbara Konig for excellent technical support.
This work was funded by Medical Research Council programme grant G9006199.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Virology, University of Glasgow, Church St., Glasgow G11 5JR, United
Kingdom. Phone and fax: 44 (0) 141 330 6249. E-mail:
David.Evans{at}vir.gla.ac.uk.
Present address: Pasteur Mérieux Connaught, 69280 Marcy-L'Etoile, France.
 |
REFERENCES |
| 1.
|
Eggers, H. J.
1977.
Selective inhibition of uncoating of echovirus 12 by rhodanine. A study on early virus-cell interactions.
Virology
78:241-252[CrossRef][Medline].
|
| 2.
|
Eggers, H. J.,
M. A. Koch,
A. Furst,
G. D. Daves,
J. J. Wilczynski, and K. Folkers.
1970.
Rhodanine: a selective inhibitor of the multiplication of echovirus 12.
Science
167:294-297[Abstract/Free Full Text].
|
| 3.
|
Filman, D. J.,
M. W. Wien,
J. A. Cunningham,
J. M. Bergelson, and J. M. Hogle.
1998.
Structure determination of echovirus 1.
Acta. Crystallogr. Sect. D
54:1261-1272[CrossRef][Medline].
|
| 4.
| Goodfellow, I., R. M. Powell, T. Ward, J. W. Almond, and D. J. Evans. Echovirus infection of
Rhabdomyosarcoma cells is inhibited by antiserum to the complement
control protein CD59. J. Gen. Virol, in press.
|
| 5.
|
Ismail-Cassim, N.,
C. Chezzi, and J. F. E. Newman.
1990.
Inhibition of the uncoating of bovine enterovirus by short chain fatty acids.
J. Gen. Virol.
71:2283-2289[Abstract/Free Full Text].
|
| 6.
|
Kaplan, G.,
D. Peters, and V. R. Racaniello.
1990.
Poliovirus mutants resistant to neutralisation with soluble cell receptors.
Science
250:1596-1599[Abstract/Free Full Text].
|
| 7.
|
Kragh-Hansen, U.
1981.
Molecular aspects of ligand binding to serum albumin.
Pharmacol. Rev.
33:17-53[Medline].
|
| 8.
|
Kraus, W.,
H. Zimmerman,
H. J. Eggers, and B. Nelsen-Salz.
1997.
Rhodanine resistance and dependence of echovirus 12: a possible consequence of capsid flexibility.
J. Virol.
77:1697-1702.
|
| 9.
|
Melnick, J. L.
1996.
Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses, p. 655-712.
In
B. N. Fields, D. M. Knipe, and P. M. Howey (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 10.
|
Mosser, A. G.,
J. Y. Sgro, and R. R. Rueckert.
1994.
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
J. Virol.
68:8193-8201[Abstract/Free Full Text].
|
| 11.
|
Muckelbauer, J. K.,
M. Kremer,
I. Minor,
G. Diana,
F. J. Dutko,
J. Groaske,
D. C. Pevear, and M. G. Rossmann.
1995.
The structure of coxsackievirus B3 at 3.5 Å resolution.
Structure
3:653-667.
|
| 12.
|
Powell, R. M.,
T. Ward,
D. J. Evans, and J. W. Almond.
1997.
Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
J. Virol.
71:9306-9312[Abstract].
|
| 13.
|
Ranallo, R. F., and E. C. Rhodes.
1998.
Lipid metabolism during exercise.
Sports Med.
26:29-42[CrossRef][Medline].
|
| 14.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, D. M. Knipe, and P. M. Howey (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 15.
|
Smyth, M.,
J. Tate,
E. Hoey,
C. Lyons,
S. Martin, and D. Stuart.
1995.
Implications for viral uncoating from the structure of bovine enterovirus.
Nat. Struct. Biol.
2:224-231[CrossRef][Medline].
|
| 16.
|
Wantanabe, M.,
C. T. Cho,
R. C. Trueworthy, and K. L. Saving.
1986.
Prolonged echoviral meningitis in a cancer patient with normal serum immunoglobulins.
Med. Pediatr. Oncol.
14:342-344[Medline].
|
| 17.
|
Ward, T.,
P. A. Pipkin,
N. A. Clarkson,
D. M. Stone,
P. D. Minor, and J. W. Almond.
1994.
Decay-accelerating factor (CD55) identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method.
EMBO J.
13:5070-5074[Medline].
|
| 18.
|
Ward, T.,
R. M. Powell,
D. J. Evans, and J. W. Almond.
1999.
Serum albumin inhibits echovirus 7 uncoating.
J. Gen. Virol.
80:283-290[Abstract].
|
| 19.
|
Ward, T.,
R. M. Powell,
P. A. Pipkin,
D. J. Evans,
P. D. Minor, and J. W. Almond.
1998.
Role for 2-microglobulin in echovirus infection of rhabdomyosarcoma cells.
J. Virol.
72:5360-5365[Abstract/Free Full Text].
|
| 20.
|
Yafal, A. G.,
G. Kaplan,
V. R. Racaniello, and J. M. Hogle.
1993.
Characterisation of poliovirus conformational alteration mediated by soluble cell receptors.
Virology
197:501-505[CrossRef][Medline].
|
Journal of Virology, April 2000, p. 3410-3412, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tuthill, T. J., Bubeck, D., Rowlands, D. J., Hogle, J. M.
(2006). Characterization of Early Steps in the Poliovirus Infection Process: Receptor-Decorated Liposomes Induce Conversion of the Virus to Membrane-Anchored Entry-Intermediate Particles. J. Virol.
80: 172-180
[Abstract]
[Full Text]